Social Audit Ltd
P O Box 111 London NW1 8XG
Telephone/Fax 44 (0)20 7586 7771

[email protected]


Dr. David Wheadon
Vice-President, Regulatory Affairs
SmithKline Beecham Pharmaceuticals
One Franklin Plaza, P.O. Box 7929
Phiiladelphia, PA 19101, USA 2 October 2000


Dear Dr Wheadon,

Following remarks you made on the recent 20-20 programme (ABC-TV) on "A Painful Withdrawal", I wrote to you on 9 September, also sending a copy by FAX. I've not heard from you, nor received any acknowledgement. But I would appreciate a reply, not only to learn more about withdrawal effects from paroxetine (Paxil/Seroxat) but also because I am shortly speaking at a seminar on Info-kinetics, on 'exchanging information with government and industry'.

I am enclosing a copy of my original letter and shall look forward to hearing from you.

Yours sincerely, 
Charles Medawar


Contents page
Correspondence with pharmaceutical companies